Skip to main content
SpringerLink
Log in

Lymphangioleiomyomatose (LAM)

Weiterer Proliferationshemmer gegen LAM erfolgreich

  • journal club
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. McCormack FX, Inoue Y, Moss J, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011;364(17):1595–1606.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Bissler JJ, Kingswood JC, Radzikowska E, et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2013; 381: 817–824.

    Article  CAS  PubMed  Google Scholar 

  3. Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis. Yao J, Taveira-DaSilva AM, Jones AM et al. Am J Respir Crit Care Med. 2014 Dec 1;190(11):1273–82.

    Article  PubMed  Google Scholar 

  4. Young L, Lee H-S, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, Barker AF, Chapman JT, Brantly ML, et al.; MILES Trial Group. Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial. Lancet Respir Med 2013;1: 445–452.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Literatur

  • Goldberg HJ, Harari S, Cottin V et al. Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study. Eur Respir J. 2015 Sep;46(3):783–94.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pneumologie und Beatmungsmedizin, Zentrum für interstitielle und seltene Lungenerkrankungen, Thoraxklinik Universitätsklinikum Heidelberg sowie Zentrum für Translationale Lungenforschung, Heidelberg (TLRC), Mitglied des Deutschen Zentrums für Lungenforschung (DZL), Amalienstr. 5, 69126, Heidelberg, Deutschland

    Michael Kreuter &  Claudia Bauer

Authors
  1. Michael Kreuter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudia Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Kreuter.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kreuter, M., Bauer, C. Weiterer Proliferationshemmer gegen LAM erfolgreich. Pneumo News 7, 31–32 (2015). https://doi.org/10.1007/s15033-015-0224-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-015-0224-6

Search

Navigation